128 related articles for article (PubMed ID: 9126677)
1. DEFIANT-II: a study of nisoldipine CC after myocardial infarction. Doppler flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy investigators.
Hall R
Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():881. PubMed ID: 9126677
[No Abstract] [Full Text] [Related]
2. Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study. The DEFIANT-II Research Group.
Eur Heart J; 1997 Jan; 18(1):31-40. PubMed ID: 9049513
[TBL] [Abstract][Full Text] [Related]
3. The DEFIANT study of left ventricular function and exercise performance after acute myocardial infarction. Doppler Flow and Echocardiology in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy Study Group.
Lewis BS; Poole-Wilson PA
Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():407-18. PubMed ID: 7947383
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular remodelling in post-myocardial infarction patients with left ventricular ejection fraction 40-50% vs 25-39%. Influence of nisoldipine treatment? An echocardiographic substudy from the DEFIANT II study.
Otterstad JE; Lubsen K; Parker A; Kirwan B; Plappert T; St John Sutton MG
Scand Cardiovasc J; 1999; 33(4):234-41. PubMed ID: 10517211
[TBL] [Abstract][Full Text] [Related]
5. Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients post myocardial infarction: results of the DEFIANT study. Doppler Flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy.
Eur Heart J; 1992 Nov; 13(11):1496-505. PubMed ID: 1464339
[TBL] [Abstract][Full Text] [Related]
6. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
Fodor JG
Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular systolic and diastolic function, and exercise capacity six to eight weeks after acute myocardial infarction. The DEFIANT Study Group. Doppler Flow and Echocardiography in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy.
Lewis BS; Emmott SN; Smyllie J; MacNeill AB; Lubsen J
Am J Cardiol; 1993 Jul; 72(2):149-53. PubMed ID: 8328375
[TBL] [Abstract][Full Text] [Related]
8. The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction.
de Nooijer RC; van der Wall EE; Cats VM; van Herpen G; van der Laarse A; Blokland JA; Jaarsma W; Arndt JW; Bruschke AV
Cardiovasc Drugs Ther; 1988 Dec; 2(5):673-8. PubMed ID: 3154643
[TBL] [Abstract][Full Text] [Related]
9. Recovery of left ventricular function following early reperfusion in acute myocardial infarction: a potential role for the calcium antagonist nisoldipine.
Sheiban I; Tonni S; Chizzoni A; Marini A; Trevi G
Cardiovasc Drugs Ther; 1997 Mar; 11(1):5-16. PubMed ID: 9140670
[TBL] [Abstract][Full Text] [Related]
10. The acute effects of intravenous nisoldipine on left ventricular function within 24 h after acute myocardial infarction.
Chin JC; van der Wall EE; Manger Cats V; van der Laarse A; Blokland JA; Pauwels EJ; Bruschke AV
Eur Heart J; 1992 Dec; 13(12):1684-91. PubMed ID: 1289100
[TBL] [Abstract][Full Text] [Related]
11. Effects of prolonged nisoldipine administration on the "hibernating" myocardium.
Pouleur H; van Eyll C; Gurné O; Rousseau MF
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S73-8. PubMed ID: 1282619
[TBL] [Abstract][Full Text] [Related]
12. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
Romano M; Cardei S; de Arcangelis E; Monteforte I; Capaldo M; Muto P; Marchegiano R; Kilama MO; Condorelli M
Am Heart J; 1997 Mar; 133(3):268-72. PubMed ID: 9060793
[TBL] [Abstract][Full Text] [Related]
13. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
Tarnow L; Sato A; Ali S; Rossing P; Nielsen FS; Parving HH
Diabetes Care; 1999 Mar; 22(3):491-4. PubMed ID: 10097934
[TBL] [Abstract][Full Text] [Related]
14. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
Langtry HD; Spencer CM
Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
[TBL] [Abstract][Full Text] [Related]
15. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
Haitas B; Meyer TE; Angel ME; Reef E
Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
[TBL] [Abstract][Full Text] [Related]
16. Calcium antagonists in the treatment early after myocardial infarction. The DEFIANT Research Group.
Schartl M
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S79-81. PubMed ID: 1282620
[No Abstract] [Full Text] [Related]
17. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
18. Effects of nisoldipine on systolic and diastolic function in postinfarction patients with reduced left ventricular function: a randomized, double-blind, placebo controlled study.
de Cock CC; Visser FC; Peels KH; Kamp O; van Eenige J; Roos JP
Eur Heart J; 1991 Sep; 12(9):1012-9. PubMed ID: 1936001
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the mechanisms underlying the changes in left ventricular filling dynamics during oral nisoldipine therapy in patients with anterior myocardial infarction.
Pouleur H; van Eyll C; Gurné O; Rousseau MF
Eur Heart J; 1992 Jul; 13(7):952-9. PubMed ID: 1644087
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction.
van der Wall EE; Cats VM; Chin JC; Pauwels EJ; Bruschke AV
Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():345-51. PubMed ID: 7947377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
